Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats

European Journal of Pharmacology

Volumn 514, Issue 2-3, 2005, Pages 201-208

  Osadchii, Oleg ^a   Norton, Gavin ^a   Woodiwiss, Angela ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Adrenergic downregulation; cAMP; Myocardial contractility; Phosphodiesterase inhibitor

Indexed keywords

8 BROMO CYCLIC AMP; AMRINONE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; MILRINONE; PENTOXIFYLLINE; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME INHIBITION; HEART CONTRACTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; AMRINONE; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; ORGAN SIZE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; ROLIPRAM;

EID: 19344363266     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.03.022     Document Type: Article

References (38)

1. M.S. Amer, A.W. Gomoll, J.L. Perhach, H.C. Ferguson, and G.R. McKinney Aberrations of cyclic nucleotide metabolism in the hearts and vessels of hypertensive rats Proc. Natl. Acad. Sci. U. S. A. 71 1974 4930 4934
2. D.C. Bode, J.R. Kanter, and L.L. Brunton Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue Circ. Res. 68 1991 1070 1079
3. M. Bohm, D. Beuckelmann, F. Diet, G. Feiler, M.J. Lohse, and E. Erdmann Properties of cardiac alpha- and beta-adrenoceptors in spontaneously hypertensive rats Naunyn-Schmiedeberg's Arch. Pharmacol. 338 1988 383 391
4. M. Bohm, F. Diet, G. Feiler, B. Kemkes, E. Kreuzer, C. Weinhold, and E. Erdmann Subsensitivity of the failing human heart to isoprenaline and milrinone is related to β-adrenoceptor downregulation J. Cardiovasc. Pharmacol. 12 1988 726 732
5. M. Bohm, F. Diet, B. Pieske, and E. Erdmann Screening of positive inotropic agents in isolated cardiac preparations from different sources J. Pharmacol. Methods 21 1989 33 44
6. iα-proteins in prehypertensive and hypertensive spontaneously hypertensive rats J. Cardiovasc. Pharmacol. 23 1994 980 987
7. M.R. Bristow, R. Ginsberg, W. Minobe, R.S. Cubicciotti, W.S. Sageman, K. Lurie, M.E. Billingham, D.C. Harrison, and E.B. Stinson Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts N. Engl. J. Med. 307 1982 205 211
8. 1-adrenergic receptors during the development of hypertension in spontaneously hypertensive rats J. Hypertens. 11 1993 787 791
9. E.S. Chung, S. Perlini, G.P. Aurigemma, R.A. Fenton, J.G. Dobson, and T.E. Meyer Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat J. Hypertens. 16 1998 1813 1822
10. C.Q. Earl, J. Linden, and W.B. Weglicki Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone J. Cardiovasc. Pharmacol. 8 1986 864 872
11. M.D. Feldman, L. Copela, J.K. Gwathmey, P. Phillips, S.E. Warren, F.J. Schoen, W. Grossman, and J.P. Morgan Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure Circulation 75 1987 331 339
12. Y. Habuchi, L.-L. Lu, S. Okamoto, T. Komori, H. Takahashi, J. Morikawa, and M. Yoshimura Decreased sensitivity to β-adrenergic stimulation of the ventricular cells isolated from the spontaneously hypertensive rat heart Clin. Exp. Pharmacol. Physiol. Suppl. 1 1995 S105 S106
13. D.S. Hodgins, and E.D. Frohlich Cardiac adenylate cyclase, cyclic nucleotide phosphodiesterase and lactate dehydrogenase in normotensive and spontaneously hypertensive rats Biochem. Pharmacol. 27 1978 1179 1185
14. K. Kajimoto, N. Hagiwara, H. Kasanuki, and S. Hosoda Contribution of phosphodiesterase isozymes to the regulation of L-type calcium current in human cardiac myocytes Br. J. Pharmacol. 121 1997 1549 1556
15. W.B. Kannel, T. Gordon, W.P. Castelli, and J.R. Margolis Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study Ann. Intern. Med. 72 1970 813 822
16. V. Klenerova, I. Albrecht, and S. Hynie The activity of adenylate cyclase and phosphodiesterase in hearts and aortas of spontaneous hypertensive rats Pharmacol. Res. Commun. 7 1975 453 462
17. K. Kumano, M.E. Upsher, and P.A. Khairallah Beta-adrenergic receptor response coupling in hypertrophied hearts Hypertension 5 Suppl. I 1983 I-175 I-183
18. H.-C. Lee, J.J. Cai, and H. Yu Effect of protein kinase C on cyclic 3′, 5′-adenosine monophosphate-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts J. Pharmacol. Exp. Ther. 270 1994 1171 1176
19. B.D. Lowes, T. Tsvetkova, E.J. Eichborn, E.M. Gilbert, and M.R. Bristow Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol Int. J. Cardiol. 81 2001 141 149
20. R. Masunaga, A. Nagasaka, Y. Sawai, N. Hayakawa, A. Nakai, K. Hotta, Y. Kato, H. Hishida, H. Takahashi, M. Naka, Y. Shimada, T. Tanaka, H. Hidaka, and M. Itoh Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters J. Mol. Cell. Cardiol. 37 2004 767 774
21. B.K. McConnell, C.S. Moravec, I. Morano, and M. Bond Troponin I phosphorylation in spontaneously hypertensive rat heart: effect of beta-stimulation Am. J. Physiol. 273 1997 H1440 H1451
22. N. Meskini, G. Nemoz, I. Okyayuz-Baklouti, M. Lagarde, and A.-F. Prigent Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation Biochem. Pharmacol. 47 1994 781 788
23. M.A. Movsesian, C.J. Smith, J. Krall, M.R. Bristow, and V.C. Manganiello Sarcoplasmic reticulum-associated cyclic adenosine 5′-monophosphate phosphodiesterase activity in normal and failing human hearts J. Clin. Invest. 88 1991 15 19
24. 2a receptor activation in rat heart Am. J. Physiol. 276 1999 H341 H349
25. G.R. Norton, A.J. Woodiwiss, W.H. Gaasch, T. Mela, E.S. Chung, G.P. Aurigemma, and T.E. Meyer Heart failure in pressure overload hypertrophy: the relative roles of ventricular remodeling and myocardial dysfunction J. Am. Coll. Cardiol. 39 2002 664 671
26. N. Prashad Reduced levels of cardiac cAMP-dependent protein kinase in spontaneously hypertensive rat J. Biol. Chem. 260 1985 10125 10131
27. S. Ramanathan, S. Shibata, T.K. Tasaki, and R.N. Ichord Cyclic AMP metabolism in the cardiac tissue of the spontaneously hypertensive rat Biochem. Pharmacol. 25 1976 223 225
28. D.J. Sahn, A. De Maria, J. Kisslo, and A. Weyman Recommendations regarding quantitation of M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
29. M. Shahid, and C.D. Nicholson Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram Naunyn-Schmiedeberg's Arch. Pharmacol. 342 1990 698 705
30. R.V. Sharma, and R.C. Bhalla Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats Biochim. Biophys. Acta. 526 1978 479 488
31. C.J. Smith, R. Huang, D. Sun, S. Ricketts, C. Hoegler, J.-Z. Ding, R.A. Moggio, and T.H. Hintze Development of decompensated dilated cardiomyopathy is associated with decreased gene expression and activity of the milrinone-sensitive cAMP phosphodiesterase PDE3A Circulation 96 1997 3116 3123
32. L.W. Stevenson, B.M. Massie, and G.S. Francis Optimising therapy for complex or refractory heart failure Am. Heart J. 135 1998 S293 S309
33. H. Tenor, S. Bartel, and E.-G. Krause Cyclic nucleotide phosphodiesterase activity in the rat myocardium: evidence of four different PDE subtypes Biomed. Biochim. Acta 46 1987 S749 S753
34. H. Von der Leyen, U. Mende, W. Meyer, J. Neumann, M. Nose, W. Schmitz, H. Scholz, J. Starbatty, B. Stein, H. Wenzlaff, V. Doring, P. Kalmar, and A. Haverich Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations Naunyn-Schmiedeberg's Arch. Pharmacol. 344 1991 90 100
35. F. Waagstein, M.R. Bristow, K. Swedberg, F. Camerini, M.B. Fowler, M.A. Silver, E.M. Gilbert, M.R. Johnson, F.G. Gross, and A. Hjalmarson Beneficial effects of metoprolol I idiopathic dilated cardiomyopathy Lancet 342 1993 1441 1446
36. K.T. Weber, J. Janicki, S.G. Schroff, R. Pick, R.M. Chen, G. Abrahams, and R.I. Bashey Collagen remodeling of the pressure-overloaded hypertrophied non-human primate myocardium Circ. Res. 62 1988 757 765
37. A.J. Woodiwiss, O.J. Tsotetsi, S. Sprott, E.J. Lancaster, T. Mela, E.S. Chung, T.E. Meyer, and G.R. Norton Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction Circulation 103 2001 155 160
38. Y.F. Xiao, and J.J. McArdle Elevated density and altered pharmacologic properties of myocardial calcium current of the spontaneously hypertensive rat J. Hypertens. 12 1994 783 790